As of 2025-07-14, the EV/EBITDA ratio of Insmed Inc (INSM) is -22.12. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. INSM's latest enterprise value is 18,610.65 mil USD. INSM's TTM EBITDA according to its financial statements is -841.27 mil USD. Dividing these 2 quantities gives us the above INSM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.4x - 14.0x | 13.6x |
| Forward P/E multiples | 12.7x - 15.0x | 13.8x |
| Fair Price | (62.47) - (68.85) | (67.04) |
| Upside | -163.6% - -170.1% | -168.3% |
| Date | EV/EBITDA |
| 2025-07-11 | -22.12 |
| 2025-07-10 | -21.79 |
| 2025-07-09 | -21.75 |
| 2025-07-08 | -21.68 |
| 2025-07-07 | -21.86 |
| 2025-07-03 | -22.04 |
| 2025-07-02 | -22.14 |
| 2025-07-01 | -22.00 |
| 2025-06-30 | -22.65 |
| 2025-06-27 | -22.41 |
| 2025-06-26 | -22.89 |
| 2025-06-25 | -23.57 |
| 2025-06-24 | -23.79 |
| 2025-06-23 | -23.69 |
| 2025-06-20 | -23.10 |
| 2025-06-18 | -22.40 |
| 2025-06-17 | -22.58 |
| 2025-06-16 | -22.86 |
| 2025-06-13 | -22.24 |
| 2025-06-12 | -21.84 |
| 2025-06-11 | -22.08 |
| 2025-06-10 | -20.55 |
| 2025-06-09 | -16.17 |
| 2025-06-06 | -16.80 |
| 2025-06-05 | -16.61 |
| 2025-06-04 | -16.82 |
| 2025-06-03 | -16.69 |
| 2025-06-02 | -16.38 |
| 2025-05-30 | -15.96 |
| 2025-05-29 | -15.85 |
| 2025-05-28 | -15.23 |
| 2025-05-27 | -15.59 |
| 2025-05-23 | -15.49 |
| 2025-05-22 | -15.19 |
| 2025-05-21 | -15.16 |
| 2025-05-20 | -15.70 |
| 2025-05-19 | -15.56 |
| 2025-05-16 | -15.61 |
| 2025-05-15 | -15.42 |
| 2025-05-14 | -15.07 |
| 2025-05-13 | -15.09 |
| 2025-05-12 | -15.53 |
| 2025-05-09 | -14.96 |
| 2025-05-08 | -15.07 |
| 2025-05-07 | -15.65 |
| 2025-05-06 | -15.56 |
| 2025-05-05 | -16.58 |
| 2025-05-02 | -16.52 |
| 2025-05-01 | -16.59 |
| 2025-04-30 | -16.45 |